{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:10:19Z","timestamp":1781277019951,"version":"3.54.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T00:00:00Z","timestamp":1569801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014438","name":"Business Finland","doi-asserted-by":"crossref","award":["THERDIAB 1843\/31\/2014"],"award-info":[{"award-number":["THERDIAB 1843\/31\/2014"]}],"id":[{"id":"10.13039\/501100014438","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.vaccine.2019.09.072","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T12:02:37Z","timestamp":1569931357000},"page":"7509-7518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9374-4583","authenticated-orcid":false,"given":"Suvi","family":"Heinim\u00e4ki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minna M.","family":"Hankaniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir-Babak","family":"Sioofy-Khojine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli H.","family":"Laitinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Hy\u00f6ty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9357-1480","authenticated-orcid":false,"given":"Vesa P.","family":"Hyt\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Vesikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Blazevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.09.072_b0005","unstructured":"GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis 2018;18(11):1211\u20131228."},{"issue":"8","key":"10.1016\/j.vaccine.2019.09.072_b0010","first-page":"1","article-title":"Enterovirus surveillance\u2013United States, 1970\u20132005","volume":"55","author":"Khetsuriani","year":"2006","journal-title":"MMWR Surveill Summ"},{"issue":"9","key":"10.1016\/j.vaccine.2019.09.072_b0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183392","article-title":"Estimating global, regional and national rotavirus deaths in children aged","volume":"12","author":"Clark","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.vaccine.2019.09.072_b0020","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/14760584.2018.1510327","article-title":"Progress on norovirus vaccine research: public health considerations and future directions","volume":"17","author":"Mattison","year":"2018","journal-title":"Expert Rev Vacc"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.072_b0025","doi-asserted-by":"crossref","first-page":"e1006136","DOI":"10.1371\/journal.ppat.1006136","article-title":"Static and evolving norovirus genotypes: implications for epidemiology and immunity","volume":"13","author":"Parra","year":"2017","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.072_b0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MOG.0000000000000022","article-title":"Epidemiology of human noroviruses and updates on vaccine development","volume":"30","author":"Ramani","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"issue":"11","key":"10.1016\/j.vaccine.2019.09.072_b0035","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/JVI.66.11.6527-6532.1992","article-title":"Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein","volume":"66","author":"Jiang","year":"1992","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.072_b0040","doi-asserted-by":"crossref","first-page":"e2027","DOI":"10.1002\/rmv.2027","article-title":"Rotavirus VP6 as a potential vaccine candidate","volume":"29","author":"Afchangi","year":"2019","journal-title":"Rev Med Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.072_b0045","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1086\/605090","article-title":"Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007\u20132008","volume":"49","author":"Wikswo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.09.072_b0050","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/1743-422X-8-297","article-title":"Epidemics of enterovirus infection in Chungnam Korea, 2008 and 2009","volume":"8","author":"Baek","year":"2011","journal-title":"Virol J"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.072_b0055","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1086\/605089","article-title":"Outbreak of life-threatening coxsackievirus B1 myocarditis in neonates","volume":"49","author":"Verma","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.072_b0060","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00125-018-4561-y","article-title":"Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes","volume":"61","author":"Sioofy-Khojine","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.vaccine.2019.09.072_b0065","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2014.01.013","article-title":"Coxsackievirus B3 VLPs purified by ion exchange chromatography elicit strong immune responses in mice","volume":"104","author":"Koho","year":"2014","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.072_b0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41426-018-0094-1","article-title":"A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity","volume":"7","author":"Zhang","year":"2018","journal-title":"Emerg Microbes Infect"},{"issue":"45","key":"10.1016\/j.vaccine.2019.09.072_b0075","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1016\/j.vaccine.2011.08.026","article-title":"Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis","volume":"29","author":"Blazevic","year":"2011","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2019.09.072_b0080","doi-asserted-by":"crossref","first-page":"e70409","DOI":"10.1371\/journal.pone.0070409","article-title":"Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice","volume":"8","author":"Tamminen","year":"2013","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2019.09.072_b0085","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/emboj\/20.7.1498","article-title":"Structural polymorphism of the major capsid protein of rotavirus","volume":"20","author":"Lepault","year":"2001","journal-title":"EMBO J"},{"issue":"11","key":"10.1016\/j.vaccine.2019.09.072_b0090","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1007\/s00705-016-2991-8","article-title":"Simple and efficient ultrafiltration method for purification of rotavirus VP6 oligomeric proteins","volume":"161","author":"Lappalainen","year":"2016","journal-title":"Arch Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.072_b0095","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/vim.2015.0141","article-title":"Mucosal antibodies induced by intranasal but not intramuscular immunization block norovirus GII.4 virus-like particle receptor binding","volume":"29","author":"Tamminen","year":"2016","journal-title":"Viral Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2019.09.072_b0100","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.4161\/hv.28858","article-title":"Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo","volume":"10","author":"Lappalainen","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10.1016\/j.vaccine.2019.09.072_b0105","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00705-015-2461-8","article-title":"Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine","volume":"160","author":"Lappalainen","year":"2015","journal-title":"Arch Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.072_b0110","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/21645515.2015.1099772","article-title":"Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine","volume":"12","author":"Blazevic","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.072_b0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/cei.12977","article-title":"Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs","volume":"189","author":"Malm","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.vaccine.2019.09.072_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104595","article-title":"Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine","volume":"171","author":"Hankaniemi","year":"2019","journal-title":"Antiviral Research"},{"issue":"9","key":"10.1016\/j.vaccine.2019.09.072_b0120","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4161\/hv.25249","article-title":"Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles","volume":"9","author":"Lappalainen","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.072_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2011.05.009","article-title":"Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus","volume":"179","author":"Koho","year":"2012","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.072_b0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jviromet.2012.01.003","article-title":"Purification of norovirus-like particles (VLPs) by ion exchange chromatography","volume":"181","author":"Koho","year":"2012","journal-title":"J Virol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.072_b0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1365-2567.2011.03516.x","article-title":"A comparison of immunogenicity of norovirus GII-4 virus-like particles and P-particles","volume":"135","author":"Tamminen","year":"2012","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.072_b0140","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.06200-11","article-title":"Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002","volume":"86","author":"Lindesmith","year":"2012","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.072_b0145","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.virol.2007.01.041","article-title":"Identification of an immunodominant CD4+ T cell epitope in the VP6 protein of rotavirus following intranasal immunization of BALB\/c mice","volume":"363","author":"McNeal","year":"2007","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.072_b0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/jps.22267","article-title":"Acceptable levels of endotoxin in vaccine formulations during preclinical research","volume":"100","author":"Brito","year":"2011","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2019.09.072_b0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4103\/0974-777X.77298","article-title":"Combination vaccines","volume":"3","author":"Skibinski","year":"2011","journal-title":"J Glob Infect Dis"},{"issue":"5138","key":"10.1016\/j.vaccine.2019.09.072_b0160","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Bachmann","year":"1993","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.072_b0165","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.4049\/jimmunol.173.5.3148","article-title":"Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors","volume":"173","author":"Fifis","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.072_b0170","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3892\/mmr.2015.3680","article-title":"Protective effect of enterovirus\u201371 (EV71) virus\u2013like particle vaccine against lethal EV71 infection in a neonatal mouse model","volume":"12","author":"Cao","year":"2015","journal-title":"Mol Med Rep"},{"issue":"10","key":"10.1016\/j.vaccine.2019.09.072_b0175","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1128\/JVI.79.10.5988-5995.2005","article-title":"Virus-specific CD4+ and CD8+ cytotoxic T-cell responses and long-term T-cell memory in individuals vaccinated against polio","volume":"79","author":"Wahid","year":"2005","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.09.072_b0180","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1128\/JVI.02179-09","article-title":"Heterotypic humoral and cellular immune responses following Norwalk virus infection","volume":"84","author":"Lindesmith","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.072_b0185","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.3389\/fmicb.2016.01570","article-title":"Norovirus-specific memory T cell responses in adult human donors","volume":"7","author":"Malm","year":"2016","journal-title":"Front Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.072_b0190","doi-asserted-by":"crossref","first-page":"e61101","DOI":"10.1371\/journal.pone.0061101","article-title":"Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore","volume":"8","author":"Aiyegbo","year":"2013","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2019.09.072_b0195","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/JVI.76.2.560-568.2002","article-title":"CD4 T cells are the only lymphocytes needed to protect mice against rotavirus shedding after intranasal immunization with a chimeric VP6 protein and the adjuvant LT(R192G)","volume":"76","author":"McNeal","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.09.072_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2018.06.012","article-title":"Intradermal and intranasal immunizations with oligomeric middle layer rotavirus VP6 induce Th1, Th2 and Th17 T cell subsets and CD4+ T lymphocytes with cytotoxic potential","volume":"157","author":"Heinim\u00e4ki","year":"2018","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.vaccine.2019.09.072_b0205","doi-asserted-by":"crossref","first-page":"e64024","DOI":"10.1371\/journal.pone.0064024","article-title":"Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS ONE"},{"issue":"30","key":"10.1016\/j.vaccine.2019.09.072_b0210","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.vaccine.2017.05.057","article-title":"Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model","volume":"35","author":"Hankaniemi","year":"2017","journal-title":"Vaccine"},{"issue":"43","key":"10.1016\/j.vaccine.2019.09.072_b0215","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1016\/j.vaccine.2015.09.043","article-title":"A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice","volume":"33","author":"Wang","year":"2015","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2019.09.072_b0220","doi-asserted-by":"crossref","first-page":"12335","DOI":"10.1128\/JVI.76.23.12335-12343.2002","article-title":"Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice","volume":"76","author":"Harrington","year":"2002","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2019.09.072_b0225","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2019.09.072_b0230","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/infdis\/jiu361","article-title":"High serum levels of norovirus genotype-specific blocking antibodies correlate with protection from infection in children","volume":"210","author":"Malm","year":"2014","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2019.09.072_b0235","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0161-5890(91)90073-S","article-title":"Rotavirus particles function as immunological carriers for the delivery of peptides from infectious agents and endogenous proteins","volume":"28","author":"Redmond","year":"1991","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2019.09.072_b0240","doi-asserted-by":"crossref","first-page":"9171632","DOI":"10.1155\/2016\/9171632","article-title":"Rotavirus recombinant VP6 nanotubes act as an immunomodulator and delivery vehicle for norovirus virus-like particles","volume":"2016","author":"Malm","year":"2016","journal-title":"J Immunol Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19313003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T22:33:17Z","timestamp":1611441197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19313003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":49,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0264410X19313003"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.072","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of three virus-derived nanoparticles as a vaccine against enteric pathogens; enterovirus, norovirus and rotavirus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}